JP2024508672A5 - - Google Patents
Info
- Publication number
- JP2024508672A5 JP2024508672A5 JP2023547592A JP2023547592A JP2024508672A5 JP 2024508672 A5 JP2024508672 A5 JP 2024508672A5 JP 2023547592 A JP2023547592 A JP 2023547592A JP 2023547592 A JP2023547592 A JP 2023547592A JP 2024508672 A5 JP2024508672 A5 JP 2024508672A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/076075 | 2021-02-08 | ||
| CN2021076075 | 2021-02-08 | ||
| CN202210088172.3 | 2022-01-25 | ||
| CN202210088172 | 2022-01-25 | ||
| PCT/US2022/015711 WO2022170280A2 (en) | 2021-02-08 | 2022-02-08 | Novel anti-cd24 antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024508672A JP2024508672A (ja) | 2024-02-28 |
| JP2024508672A5 true JP2024508672A5 (https=) | 2025-02-18 |
| JPWO2022170280A5 JPWO2022170280A5 (https=) | 2025-02-18 |
Family
ID=82741874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547592A Pending JP2024508672A (ja) | 2021-02-08 | 2022-02-08 | 新規抗ｃｄ２４抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240052052A1 (https=) |
| EP (1) | EP4288099A4 (https=) |
| JP (1) | JP2024508672A (https=) |
| KR (1) | KR20230143177A (https=) |
| CN (1) | CN117412770A (https=) |
| AU (1) | AU2022217072A1 (https=) |
| CA (1) | CA3210934A1 (https=) |
| CO (1) | CO2023011463A2 (https=) |
| IL (1) | IL304898A (https=) |
| MX (1) | MX2023009238A (https=) |
| TW (1) | TW202241956A (https=) |
| WO (1) | WO2022170280A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024251257A1 (en) * | 2023-06-09 | 2024-12-12 | TJ Biopharma (Shanghai) Co., Ltd. | Anti-cd24 antibodies and uses thereof |
| GB202316777D0 (en) | 2023-11-01 | 2023-12-13 | Cambridge Entpr Ltd | New therapeutic use |
| WO2025101970A1 (en) * | 2023-11-08 | 2025-05-15 | Pheast Therapeutics, Inc. | Cd24 antibodies |
| WO2025128830A1 (en) * | 2023-12-12 | 2025-06-19 | The Methodist Hospital | Therapeutic lilrb regulation for treating neurological disorders |
| WO2025132836A1 (en) * | 2023-12-19 | 2025-06-26 | Pentixapharm Ag | Antibodies against cd24 |
| WO2025159754A1 (en) * | 2024-01-25 | 2025-07-31 | China Medical University | Therapeutic cd24 humanized monoclonal antibodies and anti-tumor translational use |
| WO2025218729A1 (en) * | 2024-04-17 | 2025-10-23 | TJ Biopharma (Shanghai) Co., Ltd. | Multifunctional molecules targeting cd24 |
| CN119161485B (zh) * | 2024-10-29 | 2026-03-24 | 上海中医药大学附属曙光医院 | 靶向GFRα3的抗体及其制备方法和在抗癌中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080002341A (ko) * | 2006-06-30 | 2008-01-04 | 재단법인서울대학교산학협력재단 | Ｃｄ２４를 표적으로 하는 암 억제방법 |
| WO2009063461A1 (en) * | 2007-11-14 | 2009-05-22 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | Methods of treating cancer using anti cd24 antibodies |
| ES3012974T3 (en) * | 2014-01-08 | 2025-04-10 | Univ Leland Stanford Junior | Targeted therapy for lung cancer |
| AU2015229448B2 (en) * | 2014-03-11 | 2020-09-03 | The Board Of Trustees Of The Leland Stanford Junior University | Anti SIRP-alpha antibodies and Bi-specific Macrophage Enhancing antibodies |
| AU2015254257B2 (en) * | 2014-04-28 | 2021-02-25 | Medicinal Chemistry Pharmaceuticals, Co., Ltd. | Anti-MUC1 antibody or antigen-binding fragment of same, and use thereof |
| US20170158753A1 (en) * | 2014-06-25 | 2017-06-08 | Integrated Biotherapeutics, Inc. | Monoclonal antibodies directed against envelope glycoproteins from multiple filovirus species |
| WO2019222082A1 (en) * | 2018-05-14 | 2019-11-21 | Oncoimmune, Inc. | Anti-cd24 compositions and uses thereof |
| KR20210143868A (ko) * | 2019-03-26 | 2021-11-29 | 포티 세븐, 인코포레이티드 | 암 치료용 다중특이성 제제 |
| BR112021026133A2 (pt) * | 2019-06-25 | 2022-02-08 | Ichilov Tech Ltd | Anticorpo anti-cd24 e usos do mesmo |
-
2022
- 2022-02-08 CN CN202280013601.9A patent/CN117412770A/zh active Pending
- 2022-02-08 CA CA3210934A patent/CA3210934A1/en active Pending
- 2022-02-08 TW TW111104626A patent/TW202241956A/zh unknown
- 2022-02-08 KR KR1020237030578A patent/KR20230143177A/ko active Pending
- 2022-02-08 EP EP22750598.9A patent/EP4288099A4/en active Pending
- 2022-02-08 US US18/264,436 patent/US20240052052A1/en active Pending
- 2022-02-08 AU AU2022217072A patent/AU2022217072A1/en active Pending
- 2022-02-08 JP JP2023547592A patent/JP2024508672A/ja active Pending
- 2022-02-08 IL IL304898A patent/IL304898A/en unknown
- 2022-02-08 WO PCT/US2022/015711 patent/WO2022170280A2/en not_active Ceased
- 2022-02-08 MX MX2023009238A patent/MX2023009238A/es unknown
-
2023
- 2023-08-29 CO CONC2023/0011463A patent/CO2023011463A2/es unknown